LifeSafe Holdings plc
('LifeSafe', the 'Group' or the
'Company')
Interim Results for the six months
ended 30 June 2024
Significant strategic progress, margin improvement and
overhead savings
LifeSafe (AIM:LIFS), a fire safety
technology business with innovative fire extinguishing and
prevention fluids and fire safety products, reports its unaudited
Interim Results for the six months ended 30 June 2024 ('H1 2024' or
the 'Period').
Financial highlights:
·
|
Significant progress executing the
Company's strategic plan, focusing on driving profitability and
positive cash generation through the evolution of the Group's pure
B2C to a B2B2C model, partnering with wholesalers to improve
LifeSafe's gross and net margins
|
·
|
Significant savings achieved at the
gross margin level driven by reduced fulfilment and commission
charges
|
·
|
Revenue reduced to £1.6 million (H1
2023: £2.9 million), reflecting the reduced gross revenue
distribution model, but slightly ahead of the Board's internal
budgets
|
·
|
Gross margin of 66.0% (H1 2023:
57.8%), an 820bps improvement year-on-year, reflective of the new
B2B2C model and sales mix to higher margin products
|
·
|
Underlying administrative expenses
reduced significantly to £1.6 million (H1 2023: £2.5 million) with
savings of over £0.9 million (36%) in overheads, largely made up of
marketing savings (£0.6 million or 52%) and warehousing and
logistics savings (£250,000 or 73%)
|
·
|
Underlying loss before interest,
tax, depreciation and amortisation1 ('underlying LBITDA') of
£436,000 (H1 2023: £760,000), slightly ahead of the Board's
internal budgets
|
·
|
Capitalised product development
spend of £235,000 (H1 2023: £161,000)
|
·
|
Net cash at 30 June 2024 was £1.1
million (31 December 2023: net debt of £171,000), improved by net
share issue proceeds of £2.1 million during the period
|
Operational highlights:
·
|
Industrial partnership and
distribution agreement with Lingjack announced in January 2024 for
the supply of LifeSafe's Thermal Runaway Fluid across Singapore, China, Malaysia, Thailand and
Indonesia
|
·
|
Industrial partnership agreement and
contract with Trinity Fire & Security Systems Ltd announced in
May 2024 for the supply of LifeSafe's new range of fire
extinguishers, filled with LifeSafe's new Multi-Purpose
Fluid
|
·
|
Successful completion of an
oversubscribed equity fundraising in May 2024, raising gross
proceeds of £2.0 million
|
Post-period highlights:
·
|
First purchase order received for
the launch of the new LifeSafe cannisters in North
America
|
·
|
First purchase orders received for
the StaySafe All-in-1 product in the Australian, Canadian and
Republic of Ireland consumer markets
|
1 Underlying LBITDA represents loss for the period before
finance expense, tax, depreciation and amortisation, and
non-underlying items.
Commenting on the Interim Results,
Dominic Berger, Chairman of LifeSafe, said:
"The investment in our direct-to-consumer marketing campaigns
successfully enhanced our brand awareness in 2023, particularly in
the US, in turn enabling us to accelerate our transition to a more
profitable distribution model. These interim results highlight the
positive impact of this strategy, with a significant reduction in
costs and improved margins, bringing us closer to
profitability.
"Alongside our consumer channel, the team have been developing
our range of cylinders and fluids. I'm pleased to report that we
are now seeing significant orders coming through. With changes in
legislation, heightened environmental focus, and because our fluids
address multiple fire types, we are very optimistic about the
growth opportunities in these new markets, supported by our
well-established partner networks which we continue to work with to
drive growth."
Investor presentation
A virtual meeting for sell-side
analysts will be held at 12.30pm today. Please contact info@lifesafetechnologies.com if you
wish to join the meeting.
The Company will also be hosting an
online presentation for retail investors to discuss the
announcement on 1 October 2024 at 5.00pm. Please email
info@lifesafetechnologies.com to register your interest.
For
further enquiries:
LifeSafe Holdings plc
|
|
Dominic Berger, Chairman
|
info@lifesafetechnologies.com
|
Neil Smith, CEO
|
|
Mike Stilwell, CFO
|
|
|
|
Zeus (Nominated Adviser &
Broker)
|
Tel: +44
(0) 20 3829 5000
|
David Foreman, Alexandra
Campbell-Harris (Investment Banking)
|
|
Emma Ayton (Sales)
|
|
Notes to Editors
LifeSafe is a fire safety technology
business that develops eco-friendly, novel and innovative fire
extinguishing and prevention fluids and life-saving fire safety
products. LifeSafe has developed a market disrupting range of
eco-friendly fire safety protection products: the StaySafe
All-in-1, a handheld eco-friendly and fully recyclable fire
extinguisher which is verified to extinguish ten different types of
fire; a new patent-pending Thermal Runaway Fluid to combat lithium
battery fires by permanently extinguishing and preventing
re-ignition; and a new Thermal Management Fluid which prevents
ignition in the first place. LifeSafe is successfully creating new
markets for the Group in fire safety and protection through its
innovative technologies, products, digital marketing and
multi-channel sales; and is continuing to develop new fluid
derivations for applications in various industrial market
sectors.
LifeSafe was admitted to trading on
AIM in July 2022 with the ticker LIFS.
For further information please
visit: https://www.lifesafeholdingsplc.com.
LinkedIn: https://www.linkedin.com/company/lifesafe-technologies
X (formerly
Twitter): https://x.com/LifesafeT
Chairman's statement
Business review
I am delighted to report on the
continued strong operational and strategic progress made by the
Group in H1 2024, just over two years since the Group was admitted
to AIM and the commercialisation of LifeSafe's core product
containing our proprietary fire extinguishing fluid.
Earlier this year, the Board took
steps to address the cost pressures experienced as LifeSafe scaled
at pace during 2023. The Group evolved its US sales model from a
pure B2C to a B2B2C model, partnering with wholesalers to improve
LifeSafe's gross and net margins. Significant savings have
been made at the gross margin level, through reduced fulfilment and
commission charges, while overheads decreased through reduced
marketing and logistics costs. This enabled us to achieve a
higher gross margin on lower revenue, reflecting the new
distribution relationship in the US. Overheads were reduced by £0.9
million (36%), with marketing costs in particular decreasing by
more than 50% and warehousing and logistics costs more than 70%
lower.
As a result, LBITDA improved
significantly in H1 2024 to a loss of £436,000 (H1 2023: £760,000),
slightly ahead of the Board's internal budgets and in line with our
journey to profitability.
Our industrial partnerships continue
to progress well. As previously mentioned, these arrangements
are key to achieving enhanced margins through bulk fluid supply via
international distribution agreements, which avoid many of the
costs associated with the direct-to-consumer supply
model.
H1 2024 also marked several
commercial milestones for LifeSafe. The Group received its
first purchase order linked to the launch of the new LifeSafe
cannisters in North America; it also received its first purchase
orders for the StaySafe All-in-1 for the Australian, Canadian and
Republic of Ireland consumer markets.
The Board has acted decisively to
address the short-term cost headwinds that impacted the Group's
financial performance in 2023. Looking ahead, the Board
expects further improvements to margins through an increased mix of
wholesale and industrial sales. The Group remains on track in
executing its strategy to build a multi-product, multi-channel,
international business, capable of delivering significant long-term
value for its shareholders.
Results
In line with the Board's
expectations, LifeSafe's revenue for H1 2024 reduced to £1.6
million (H1 2023: £2.9 million) as a result of moving to a new
distribution relationship in the US market.
Gross profit in H1 2024 reduced to
£1.1 million (H1 2023: £1.7 million) reflecting a significantly
improved gross margin of 66.0% (H1 2023: 57.8%) due to savings on
fulfilment and commission charges achieved through the new US
distribution relationship.
Notably, underlying administrative
expenses for H1 2024 saw a material reduction to £1.6 million (H1
2023: £2.5 million), the most significant savings being made in
marketing (£0.6 million or 52%) and warehousing and logistics
(£250,000 or 73%), again, arising from the new US distribution
relationship.
As a result, the Group's underlying
loss before interest, tax, depreciation and
amortisation1 ('LBITDA') was significantly reduced to
£436,000 (H1 2023: £760,000), before non-underlying share-based
payment charges of £75,000 (H1 2023: £413,000). The
underlying loss before tax2 was £563,000 (H1 2023:
£849,000).
The basic and diluted earnings per
share were (2.0) pence (H1 2023: (5.9) pence).
Cash and cash equivalents as at 30
June 2024 was £1.1 million (31 December 2023: £60,000) improved by
share issue proceeds of £2.1 million. Net cash at 30 June
2024 was £1.1 million (31 December 2023: net debt
£171,000).
Inventory at 30 June 2024 was
£444,000 (31 December 2023: £626,000) reflecting previously
procured stock to satisfy expected demand in Q4 2023 being sold
through.
Trade and other receivables at 30
June 2024 were £658,000 (31 December 2023: £1.1 million,
which included £375,000 in
respect of monies due from investors in relation to the placing and
subscription of shares in December 2023 and a significant VAT
debtor of £422,000).
Trade and other payables at 30 June
2024 were £455,000 (31 December 2023: £896,000), the reduction
reflecting the offset of increased tax owing against the VAT debtor
at the year-end.
Borrowings at 30 June 2024
significantly reduced to £14,000 and related to a Coronavirus
Bounce Back Loan (31 December 2023: £231,000
relating to a Coronavirus Bounce Back Loan, loans for the Company's annual
insurance premia and a supplier invoice finance
facility).
1 Underlying LBITDA represents loss for the period before
finance expense, tax, depreciation and amortisation, and
non-underlying items.
2 Underlying loss before tax represents loss for the period
before tax and non-underlying items.
Placing, share subscription and retail offer of
shares
In May 2024, the Company
successfully completed an equity placing, subscription, and retail
offer, raising gross proceeds of £2.0 million.
We are grateful for the support of
both new and existing shareholders, whose investment will be used
to maximise the business opportunity in front of us.
Research and development,
technology and intellectual property
The Group has continued the
development of its innovative new products and fluid derivatives
through its existing industrial partnerships and in response to new
industry demand.
Capitalised expenditure on
technology development during the Period amounted to £235,000 (H1
2023: £161,000).
As previously announced,
the Group has developed fluorine-free derivatives
of its existing fluids, in response to European legislation,
effective from July 2025, which will
prohibit the use of fire-fighting foam containing perfluorooctanoic
acid ('PFOA'). This follows similar legislation in North
America and Australia. The global
market for these soon-to-be banned foam extinguishers is valued at
$1 billion annually (source: Grandview Research), representing a
significant growth opportunity for LifeSafe.
Outlook
We are pleased to report that the
evolution of the Group's B2C strategy towards a B2B2C model in the
US has significantly improved gross margins and reduced overheads
in the first half of 2024. This reinforces the Board's
confidence that LifeSafe can achieve profitability at lower volumes
than under the previous direct-to-consumer model.
We remain focused on enhancing our
consumer proposition at this improved margin by expanding our
product range, entering new territories, and increasing
distribution channels, particularly complementary to digital.
Our focus remains on increasing profitability and cash
generation of the Group.
In parallel, we continue to make
excellent progress with our industrial and wholesale partners in
the development and distribution of our new fluids. Working
with large industry leaders inevitably takes time and investment,
but it is through this evolution that we will unlock long-term
value for our shareholders and position LifeSafe as a recognised
leader in fluid technology.
Our recent fundraise has provided us
with the necessary resources to continue executing this plan and
our path toward profitability. Once again, I'd like to extend my
gratitude to both our new and existing shareholders for their
support and we as a Board look forward to a successful and
profitable future.
Dominic Berger
Executive Chairman
29 September 2024
Consolidated statement of comprehensive
income
For
the six months ended 30 June 2024
|
|
(Unaudited)
|
(Unaudited)
|
(Audited)
|
|
|
Six months ended 30 June
2024
|
Six
months ended 30 June 2023
|
Year
ended 31 December 2023
|
Note
|
Before non-underlying
items
£000
|
Non-underlying
items
(note 5)
£000
|
Total
£000
|
Before
non-underlying items
£000
|
Non-underlying items
(note
5)
£000
|
Total
£000
|
Before
non-underlying items
£000
|
Non-underlying items (note 5)
£000
|
Total
£000
|
Revenue
|
3
|
1,607
|
-
|
1,607
|
2,890
|
-
|
2,890
|
5,879
|
-
|
5,879
|
Cost of sales
|
|
(546)
|
-
|
(546)
|
(1,220)
|
-
|
(1,220)
|
(2,490)
|
-
|
(2,490)
|
Gross profit
|
|
1,061
|
-
|
1,061
|
1,670
|
-
|
1,670
|
3,389
|
-
|
3,389
|
Administrative expenses
|
|
(1,608)
|
(75)
|
(1,683)
|
(2,496)
|
(413)
|
(2,909)
|
(4,912)
|
(595)
|
(5,507)
|
Loss from operations
|
|
(547)
|
(75)
|
(622)
|
(826)
|
(413)
|
(1,239)
|
(1,523)
|
(595)
|
(2,118)
|
Finance expense (net)
|
6,5
|
(16)
|
-
|
(16)
|
(23)
|
-
|
(23)
|
(93)
|
-
|
(93)
|
Loss before tax
|
|
(563)
|
(75)
|
(638)
|
(849)
|
(413)
|
(1,262)
|
(1,616)
|
(595)
|
(2,211)
|
Taxation
|
7
|
-
|
-
|
-
|
(52)
|
-
|
(52)
|
(7)
|
-
|
(7)
|
Loss for the period
|
|
(563)
|
(75)
|
(638)
|
(901)
|
(413)
|
(1,314)
|
(1,623)
|
(595)
|
(2,218)
|
Other comprehensive income
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive
income
|
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Total comprehensive expense
|
|
(563)
|
(75)
|
(638)
|
(901)
|
(413)
|
(1,314)
|
(1,623)
|
(595)
|
(2,218)
|
Basic and diluted loss per share (pence)
|
8
|
|
|
(2.0)
|
|
|
(5.9)
|
|
|
(9.5)
|
All amounts relate to continuing
activities.
Consolidated statement of financial position
As
at 30 June 2024
|
Note
|
(Unaudited)
30 June 2024 £000
|
(Unaudited)
30 June 2023 £000
|
(Audited)
31 Dec 2023 £000
|
Non-current
assets
|
|
|
|
|
Intangible assets
|
|
914
|
580
|
788
|
Property, plant and
equipment
|
|
10
|
12
|
11
|
|
|
924
|
592
|
799
|
Current
assets
|
|
|
|
|
Inventories
|
|
444
|
1,025
|
626
|
Trade and other
receivables
|
9
|
658
|
436
|
1,068
|
Cash and cash equivalents
|
10
|
1,103
|
24
|
60
|
|
|
2,205
|
1,485
|
1,754
|
Total
assets
|
|
3,129
|
2,077
|
2,553
|
Current
liabilities
|
|
|
|
|
Trade and other payables
|
11
|
(455)
|
(782)
|
(896)
|
Borrowings
|
12
|
(7)
|
(449)
|
(220)
|
Other provisions
|
|
-
|
(24)
|
-
|
|
|
(462)
|
(1,255)
|
(1,116)
|
Non-current
liabilities
|
|
|
|
|
Borrowings
|
12
|
(7)
|
(15)
|
(11)
|
|
|
(7)
|
(15)
|
(11)
|
Total
liabilities
|
|
(469)
|
(1,270)
|
(1,127)
|
Net assets
|
|
2,660
|
807
|
1,426
|
Equity attributable to equity
holders of the Parent
|
|
|
|
|
Called up share capital
|
13
|
479
|
221
|
272
|
Shares to be issued
reserve
|
|
-
|
-
|
103
|
Share premium account
|
14
|
7,124
|
4,152
|
5,431
|
Share-based payment
reserve
|
14
|
1,435
|
1,270
|
1,360
|
Accumulated losses
|
14
|
(6,378)
|
(4,836)
|
(5,740)
|
Total
equity
|
|
2,660
|
807
|
1,426
|
Consolidated statement of changes in equity
For
the six months ended 30 June 2024
|
Share
capital
£000
|
Shares to
be issued reserve
£000
|
Share
premium
account
£000
|
Share-based payment
reserve
£000
|
Accumulated
losses
£000
|
Total
equity
£000
|
Balance at 1 January 2023
(Audited)
|
221
|
-
|
4,152
|
857
|
(3,522)
|
1,708
|
Comprehensive
income
|
|
|
|
|
|
|
Loss for
the year
|
-
|
-
|
-
|
-
|
(2,218)
|
(2,218)
|
Share-based
payments
|
-
|
-
|
-
|
503
|
-
|
503
|
Transactions with
owners:
|
|
|
|
|
|
|
Shares
issued for cash
|
51
|
-
|
1,455
|
-
|
-
|
1,506
|
Shares to
be issued
|
-
|
103
|
-
|
-
|
-
|
103
|
Share issue
costs
|
-
|
-
|
(176)
|
-
|
-
|
(176)
|
Balance at 31 December 2023
(Audited)
|
272
|
103
|
5,431
|
1,360
|
(5,740)
|
1,426
|
Balance at 1 January 2024
(Audited)
|
272
|
103
|
5,431
|
1,360
|
(5,740)
|
1,426
|
Comprehensive
income
|
|
|
|
|
|
|
Loss for
the period
|
-
|
-
|
-
|
-
|
(638)
|
(638)
|
Share-based
payments
|
-
|
-
|
-
|
75
|
-
|
75
|
Transactions with
owners:
|
|
|
|
|
|
|
Shares
issued for cash
|
200
|
-
|
1,800
|
-
|
-
|
2,000
|
Shares to
be issued
|
7
|
(103)
|
96
|
-
|
-
|
-
|
Share issue
costs
|
-
|
-
|
(203)
|
-
|
-
|
(203)
|
Balance at 30 June 2024
(Unaudited)
|
479
|
-
|
7,124
|
1,435
|
(6,378)
|
2,660
|
Consolidated statement of cash flows
For
the six months ended 30 June 2024
|
Note
|
(Unaudited)
Six months ended
30 June 2024 £000
|
(Unaudited)
Six months ended
30 June 2023 £000
|
(Audited)
Year ended
31 Dec 2023 £000
|
Cash flows from operating
activities
|
|
|
|
|
Loss before taxation from continuing
operations
|
|
(638)
|
(1,262)
|
(2,211)
|
Adjustments for non-cash/non-operating
items:
|
|
|
|
|
Depreciation of property, plant and
equipment
|
|
1
|
1
|
2
|
Amortisation of intangible
assets
|
|
110
|
65
|
130
|
Equity-settled share-based
payments
|
|
75
|
413
|
503
|
Finance expense (net)
|
|
16
|
22
|
93
|
Operating cash flows before
movements in working
capital
|
|
(436)
|
(761)
|
(1,483)
|
Decrease/(increase) in
inventories
|
|
182
|
(520)
|
(184)
|
Decrease/(increase) in trade and
other receivables
|
|
74
|
67
|
(211)
|
Decrease in trade and other
payables
|
|
(399)
|
(218)
|
(179)
|
Cash used in
operations
|
|
(579)
|
(1,432)
|
(2,057)
|
Corporation tax received
|
|
-
|
81
|
169
|
Net cash used in operating
activities
|
|
(579)
|
(1,351)
|
(1,888)
|
Cash flows used in investing
activities
|
|
|
|
|
Purchase of property, plant and
equipment
|
|
-
|
(4)
|
(3)
|
Purchase of intangibles
|
|
(235)
|
(161)
|
(435)
|
Interest received
|
|
3
|
-
|
-
|
Net cash used in investing
activities
|
|
(232)
|
(165)
|
(438)
|
Cash flows from financing
activities
|
|
|
|
|
Shares issued for cash (net of
expenses)
|
|
2,082
|
-
|
1,114
|
Proceeds from borrowings
|
|
-
|
505
|
893
|
Repayment of borrowings
|
|
(210)
|
(118)
|
(694)
|
Loan interest paid
|
|
(12)
|
(13)
|
(91)
|
Other interest paid
|
|
(6)
|
-
|
(2)
|
Net cash generated by
financing activities
|
|
1,854
|
374
|
1,220
|
Net increase/(decrease) in cash and
cash equivalents
|
|
1,043
|
(1,142)
|
(1,106)
|
Cash and cash equivalents at the
beginning of period
|
|
60
|
1,166
|
1,166
|
Cash and cash equivalents at
the end of period
|
10
|
1,103
|
24
|
60
|
Notes to the unaudited condensed interim consolidated
financial statements
1. General
information
These interim consolidated financial
statements were approved by the Board of Directors on 30 September
2024.
2. Basis of
preparation
These unaudited interim consolidated
financial statements of the Group are for the six months ended 30
June 2024.
The condensed interim consolidated
financial statements for the six months to 30 June 2024 do not
include all the information and disclosures required in the annual
financial statements and have not been audited or reviewed by an
auditor pursuant to the Auditing Practices Board guidance on Review
of Interim Financial Information. However, selected
explanatory notes are included to explain events and transactions
that are significant for an understanding of the changes in the
Group's financial position and performance in the
period.
The condensed interim consolidated
financial statements for the six months to 30 June 2024 have been
prepared on the basis of the accounting policies expected to be
adopted for the year ending 31 December 2024. These
accounting policies are drawn up in accordance with adopted
International Accounting Standards ('IAS') and International
Financial Reporting Standards ('IFRS') as issued by the
International Accounting Standards Board and adopted by the
EU.
AIM-listed companies are not
required to comply with IAS 34 'Interim Financial Reporting' and
accordingly the Company has taken advantage of this
exemption.
3. Revenue from
customers
Geographic reporting
|
(Unaudited)
Six months
ended
30 June 2024
£000
|
(Unaudited)
Six months
ended
30 June
2023
£000
|
(Audited)
Year
ended
31 Dec
2023
£000
|
Revenue
|
|
|
|
United Kingdom
|
367
|
806
|
1,552
|
North America
|
1,178
|
2,067
|
4,306
|
Europe
|
47
|
17
|
21
|
Rest of the World
|
15
|
-
|
-
|
|
1,607
|
2,890
|
5,879
|
During H1 2024, the Group evolved its US sales model from a pure B2C to a
B2B2C model, partnering with wholesalers to improve LifeSafe's
gross and net margins through avoiding direct fulfilment and
commission costs, as well as reducing the significant digital
advertising expenses associated with selling directly through
digital channels. As a result, the Group's revenue has
decreased alongside significantly reduced costs.
4. Segmental
reporting
The Chief Operating Decision Maker
('CODM') has been determined to be the Board of Directors.
The CODM reviews the Group's internal reporting in order to assess
performance and allocate resources. The CODM has determined
that there is one single operating segment being the sale of fire
extinguishing and related products. Information concerning
geographical revenue is disclosed in note 3.
5. Non-underlying items
|
(Unaudited)
Six months
ended
30 June 2024
£000
|
(Unaudited)
Six months
ended
30 June
2023
£000
|
(Audited)
Year
ended
31 Dec
2023
£000
|
Share-based payment
charges
|
75
|
413
|
503
|
Other non-underlying
costs
|
-
|
-
|
92
|
|
75
|
413
|
595
|
Share-based payment charges
The total charge recognised for the
Period in relation to share-based payments amounted to
£75,000.
Other non-underlying costs
Other non-underlying costs of
£92,000 were provided in 2023 in relation to employment termination
costs.
The Group operates equity-settled
share-based remuneration schemes for employees. The terms and
conditions of the grants are detailed below:
Date of grant
|
No.
of
options
|
Exercise
price (£)
|
Vesting
conditions
|
Contractual life
of
options
|
30 September 20211
|
1,495,650
|
0.48
|
IPO
|
10
years
|
11 October 20211
|
1,645,200
|
0.48
|
IPO/market
capitalisation
|
10
years
|
29 March 20221
|
1,645,200
|
0.16
|
12 months
from admission date
|
10
years
|
26 July 2022
|
1,167,301
|
0.75
|
Total
shareholder return
|
10
years
|
13 October 2022
|
974,965
|
0.75
|
Total
shareholder return
|
10
years
|
1 The number of share options granted, and the corresponding
exercise price, are shown after the Company's 49 for 1 bonus issue
of shares on 9 May 2022.
6. Finance
expense
|
(Unaudited)
Six months
ended
30 June 2024
£000
|
(Unaudited)
Six months
ended
30 June
2023
£000
|
(Audited)
Year
ended
31 Dec
2023
£000
|
Interest on bank loans
|
-
|
1
|
1
|
Interest on other loans
|
12
|
22
|
90
|
Other interest (net)
|
4
|
-
|
2
|
|
16
|
23
|
93
|
7. Income tax
expense
No income has yet been recognised in
H1 2024 in relation to R&D tax credits available from HMRC
through the SME R&D relief scheme for 2024.
8. Loss per share
Loss per share is calculated as
follows:
|
(Unaudited)
Six months
ended
30 June
2024
|
(Unaudited)
Six months
ended
30 June
2023
|
(Audited)
Year
ended
31 Dec
2023
|
Basic and diluted loss per share
(pence)
|
(2.0)
|
(5.9)
|
(9.5)
|
The calculations of basic and
diluted loss per share are based upon:
Loss for the period attributable to
owners of the Parent (£000)
|
(638)
|
(1,314)
|
(2,218)
|
|
|
|
|
Weighted average number of ordinary
shares
|
31,233,871
|
22,108,050
|
23,374,334
|
The calculation of the basic loss
per share is based on the results attributable to ordinary
shareholders divided by the weighted average number of shares in
issue during the period.
The weighted average number of
shares in issue is used as the denominator in calculating the basic
loss per share. As the Group is loss making the effect of
instruments that convert into ordinary shares is considered
anti-dilutive, hence there is no difference between the diluted and
non-diluted loss per share.
9. Trade and other
receivables
|
(Unaudited)
30 June 2024
£000
|
(Unaudited)
30 June
2023
£000
|
(Audited)
31 Dec
2023
£000
|
Amounts falling due within one year:
|
|
|
|
Trade receivables
|
433
|
24
|
9
|
Other receivables
|
55
|
119
|
458
|
Taxation and social
security
|
107
|
154
|
468
|
Prepayments and accrued
income
|
63
|
139
|
133
|
|
658
|
436
|
1,068
|
Other receivables at 31 December
2023 included £375,000 in respect of monies due from shareholders
in relation to the placing and subscription of shares in December
2023, the majority of which had been received by the Company's
prevailing Broker but not yet transferred to the Company at the
year end. These funds were received in January
2024.
10. Cash and cash equivalents
|
(Unaudited)
30 June 2024
£000
|
(Unaudited)
30 June
2023
£000
|
(Audited)
31 Dec
2023
£000
|
Cash at bank available on
demand
|
1,103
|
24
|
60
|
|
1,103
|
24
|
60
|
11. Trade and other payables
|
(Unaudited)
30 June 2024
£000
|
(Unaudited)
30 June
2023
£000
|
(Audited)
31 Dec
2023
£000
|
Trade payables
|
238
|
515
|
432
|
Other payables
|
17
|
2
|
12
|
Accruals
|
103
|
113
|
231
|
Other taxation and social
security
|
97
|
152
|
221
|
|
455
|
782
|
896
|
12. Borrowings
|
(Unaudited)
30 June 2024
£000
|
(Unaudited)
30 June
2023
£000
|
(Audited)
31 Dec
2023
£000
|
Current:
|
|
|
|
Bank loans
|
7
|
7
|
8
|
Other loans
|
-
|
442
|
212
|
Non-current:
|
|
|
|
Bank loans
|
7
|
15
|
11
|
|
14
|
464
|
231
|
Bank loans comprise a Coronavirus
Bounce Back Loan Scheme loan provided by HSBC. The loan was
taken out in May 2020 and matures five years after this date.
The loan incurs interest of 2.5%.
Other loans at 31 December 2023
comprised monies to fund certain of the Group's annual insurance
premia and a supplier invoice finance facility. These were
fully repaid at the Period end.
13. Share capital
|
(Unaudited)
30 June 2024
£000
|
(Unaudited)
30 June
2023
£000
|
(Audited)
31 Dec
2023
£000
|
Called up share capital
|
|
|
|
Ordinary shares of £0.01
each
|
479
|
221
|
272
|
|
479
|
221
|
272
|
Called up share capital
Called up share capital represents
the nominal value of shares that have been issued.
All classes of share have full
voting, dividends, and capital distribution rights.
On 14 May 2024, the Company
announced a proposed placing and share subscription at £0.10 per
share to raise approximately £1.6 million and £0.1 million
respectively, and up to £0.3 million through a retail offer.
The proposed placing resulted in the issue of 16,050,000 shares on
31 May 2024, raising gross proceeds of £1.6 million. The
share subscription resulted in the issue of 950,000 shares on 31
May 2024, raising gross proceeds of £0.1 million. The retail
offer resulted in the issue of 3,000,000 shares on 31 May 2024,
raising gross proceeds of £0.3 million.
In total 20,000,000 shares were
issued through the placing, share subscription and retail offer,
raising gross proceeds of £2.0 million and taking the number of
shares in issue to 47,875,983. The costs of issue amounted to
£0.2 million.
On 30 May 2024, a General Meeting of
the Company was held in which the Directors obtained authority to
allot the placing, subscription and retail offer shares and the
disapplication of pre-emption rights in this respect.
14. Reserves
Share premium account
This represents the excess value
recognised from the issue of ordinary shares above nominal
value.
Share-based payment reserve
This represents the cumulative fair
value of share options charged to the consolidated statement of
comprehensive income net of the transfers to the profit and loss
reserve on exercised and cancelled/lapsed options.
Accumulated losses
This represents cumulative net gains
and losses less distributions made.
15. Availability
Further copies of this interim
announcement are available on the LifeSafe Holdings plc investor
relations website, www.lifesafeholdingsplc.com.
- Ends -